Technical Analysis for GBIO - Generation Bio Co.

Grade Last Price % Change Price Change
F 2.21 1.38% 0.03
GBIO closed up 1.38 percent on Friday, November 1, 2024, on 75 percent of normal volume.
Earnings due: Nov 7
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Fell Below 20 DMA Bearish 1.38%
Bollinger Band Squeeze Range Contraction 1.38%
Shooting Star Candlestick Bearish -5.96%
Lizard Bearish Bearish Day Trade Setup -5.96%
Bollinger Band Squeeze Range Contraction -5.96%
Doji - Bearish? Reversal -5.96%
20 DMA Support Bullish -7.53%
MACD Bullish Signal Line Cross Bullish -7.53%

   Recent Intraday Alerts

Alert Time
Possible Inside Day about 19 hours ago
20 DMA Resistance about 22 hours ago
10 DMA Resistance about 22 hours ago
Rose Above 20 DMA about 23 hours ago
Rose Above 10 DMA about 23 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Generation Bio Co. Description

Generation Bio is an innovative genetic medicines company focused on creating a new class of gene therapy to provide durable, redosable treatments for patients suffering from both rare and prevalent diseases. The company’s non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA; a novel cell-targeted lipid nanoparticle delivery system, or ctLNP; and an established, scalable capsid-free manufacturing process. The company is designing therapies to provide targeted delivery of genetic payloads that include large and multiple genes across a broad array of tissues, and to be redosable for individualized and extended treatment throughout a patient’s life. The platform is designed to expand access to treatments for rare diseases and to address prevalent diseases through efficient, scalable manufacturing.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Emerging Technologies Molecular Biology Rare Diseases Gene Therapy Manufacturing Process Lipid Applied Genetics Gene Delivery

Is GBIO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 4.65
52 Week Low 0.9898
Average Volume 104,617
200-Day Moving Average 2.75
50-Day Moving Average 2.44
20-Day Moving Average 2.31
10-Day Moving Average 2.26
Average True Range 0.18
RSI (14) 44.44
ADX 19.06
+DI 13.24
-DI 22.78
Chandelier Exit (Long, 3 ATRs) 2.09
Chandelier Exit (Short, 3 ATRs) 2.61
Upper Bollinger Bands 2.49
Lower Bollinger Band 2.12
Percent B (%b) 0.24
BandWidth 16.10
MACD Line -0.06
MACD Signal Line -0.06
MACD Histogram 0.0009
Fundamentals Value
Market Cap 146.03 Million
Num Shares 66.1 Million
EPS -1.97
Price-to-Earnings (P/E) Ratio -1.12
Price-to-Sales 46.08
Price-to-Book 0.57
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.44
Resistance 3 (R3) 2.45 2.39 2.40
Resistance 2 (R2) 2.39 2.33 2.38 2.38
Resistance 1 (R1) 2.30 2.30 2.27 2.29 2.37
Pivot Point 2.24 2.24 2.23 2.23 2.24
Support 1 (S1) 2.15 2.18 2.12 2.14 2.05
Support 2 (S2) 2.09 2.15 2.08 2.04
Support 3 (S3) 2.00 2.09 2.02
Support 4 (S4) 1.99